Last reviewed · How we verify
Gene Therapy Product-MCO-010
At a glance
| Generic name | Gene Therapy Product-MCO-010 |
|---|---|
| Sponsor | Nanoscope Therapeutics Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
- Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
- Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |